# From alkylating to shape-shifting G-quadruplex ligands: the RHAU peptide story

**Authors:** Lessandro De Paepe, Simona Marzano, Camille Vesschemoet, Jussara Amato, Bruno Pagano, Enrico Cadoni, Annemieke Madder

PMC · DOI: 10.1093/nar/gkag039 · 2026-01-29

## TL;DR

This paper explores how modified peptides can bind and stabilize G-quadruplex structures in DNA, offering a new approach for targeting these structures with high specificity.

## Contribution

The study introduces a novel peptide-based methodology for covalent G4 targeting using photoactivatable moieties derived from the RHAU helicase.

## Key findings

- Nine modified RHAU peptides showed moderate to high alkylation yields toward G4 structures.
- N-terminal modifications of RHAU18 significantly enhanced G4 stabilizing potential.
- The study provides insights into how individual amino acid modifications affect G4 binding behavior.

## Abstract

G-quadruplexes (G4s) are non-canonical secondary nucleic acid structures with important biological implications in telomere elongation and gene expression. A large number of small molecules have been developed to bind and even covalently target these structures, enhancing the potency and duration of binding. Alternatively, peptide-based ligands have been studied and shown to offer several advantages, including high specificity, a modular design, and ease of synthesis. In this work, we describe a peptide-based methodology for covalent G4-targeting, based on the introduction of two photoactivatable moieties in a peptide derived from the RHAU helicase. Rational insertion of crosslinkers at different positions yielded nine different peptides, which were evaluated for their G4-stabilizing effect and alkylation potential. Moderate to high alkylation yields towards G4s were obtained. The G4 stabilizing potential drastically increased for N-terminal modifications of the RHAU18 peptide. This led to the design of a further series of peptides with varying N-terminal residues to gain insight in the stabilization potential of each single amino acid modification and provided a comprehensive study of the binding behaviour of modified RHAU peptides.

Graphical Abstract

## Linked entities

- **Proteins:** DHX36 (DEAH-box helicase 36)

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, RHOB (ras homolog family member B) [NCBI Gene 388] {aka ARH6, ARHB, MST081, MSTP081, RHOH6}, DHX36 (DEAH-box helicase 36) [NCBI Gene 170506] {aka DDX36, G4R1, MLEL1, RHAU}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** Cancer (MESH:D009369)
- **Chemicals:** Rhodamine B (MESH:C029773), 4,4-dimethyl-4-silapentane-1-sulfonic acid (MESH:C009580), meta-cresol (MESH:C042041), Dde (MESH:D003633), D2O. (MESH:D017666), dimethylsulfide (MESH:C004784), peptides (MESH:D010455), nitrogen mustards (MESH:D008466), sulphur (MESH:D013455), Na+ (MESH:D012964), Met (MESH:D008715), DCM (-), Furan (MESH:C039281), thymine (MESH:D013941), cytosine (MESH:D003596), salt (MESH:D012492), amino acid (MESH:D000596), Trp (MESH:D014364), HCl (MESH:D006851), singlet oxygen (MESH:D026082), nitrogen (MESH:D009584), Phe (MESH:D010649), guanine (MESH:D006147), quinone methides (MESH:C068040), trifluoroacetic acid (MESH:D014269), benzophenones (MESH:D001577), imidazole (MESH:C029899), Benzophenone (MESH:C047723), NaCl (MESH:D012965), His (MESH:D006639), KCl (MESH:D011189), water (MESH:D014867), HBTU (MESH:C074712), adenine (MESH:D000225), piperidine (MESH:C032727), MB (MESH:D008751), G4 (MESH:D004003), hydrogen (MESH:D006859), ammonium iodide (MESH:C582942), Ala (MESH:D000409), polyacrylamide (MESH:C016679), silver (MESH:D012834), hydroxylamine HCl (MESH:D019811), DIPEA (MESH:C027070), phenols (MESH:D010636), resin (MESH:D012116), Tyr (MESH:D014443), benzoylphenyl-alanine (MESH:C053764), acetic anhydride (MESH:C031800), lysine (MESH:D008239), oxygen (MESH:D010100), K+ (MESH:D011188), K2HPO4 (MESH:C013216), amines (MESH:D000588), RB (MESH:D012395), N-methyl mesoporphyrin IX (MESH:C065420), phosphate (MESH:D010710), pyrimidine (MESH:C030986)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** T95-2T — Homo sapiens (Human), Esophageal squamous cell carcinoma, Cancer cell line (CVCL_3174)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12852953/full.md

---
Source: https://tomesphere.com/paper/PMC12852953